Bitolterol

Bitolterol belongs to the pharmacological class of Beta 2-adrenergic agonists. Bitolterol appears to have bronchodilating properties.

Bitolterol had been approved for relieving symptoms as well as for the treatment as well as maintenance of episodes of asthma and also chronic obstructive pulmonary disease.

Bitolterol belongs to the pharmacological class of Beta 2-adrenergic agonists. Bitolterol appears to have bronchodilating properties.

Bitolterol had been approved for relieving symptoms as well as for the treatment as well as maintenance of episodes of asthma and also chronic obstructive pulmonary disease.

Bitolterol is said to be an adrenergic beta-2 agonist. Asthma is caused from a narrowing of the bronchial tubes. This narrowing is caused by muscle spasms and also inflammation within the bronchial tubes. Agonism of the beta-2 adrenergic receptors caused by bitolterol leading to a relaxation of the smooth muscles which are surrounding these airway tubes which then increases the diameter as well as ease of air flow through the tubes.

Bitolterol was available in the form of the inhalation solution.

Bitolterol was available in the form of the inhalation solution.

Bitolterol had been used in the treatment of the following conditions

• Asthma
• Chronic obstructive pulmonary disease

Bitolterol can help to relieve symptoms and also for the treatment and maintenance of asthma and chronic obstructive pulmonary disease.

Bitolterol was used following clinical indications/conditions:

• Asthma
• Chronic obstructive pulmonary disease

Asthma and COPD

Bitolterol 0.2% Inhalation Solution

Bitolterol 0.37 Mg/inh Inhalation Aerosol

Inhalation solution

Smoking cessation and maintaining health is a must.

Caffeine should be avoided or limited to use as it might lead to the risk of nausea, palpitations, nervousness, rapid heartbeat, etc.

Alcohol intake should be avoided in the patients, especially with an underlying liver disorder or liver dysfunction.

Diet containing food with high sugar content or carbohydrates should be restricted.This includes candies,chips pies, cakes, honey,cookies, jams, and bread. It is also advised to limit or reduce the intake of cholesterol and saturated fat and instead choose poultry, lean meat or fish.

The dietary restrictions should be individualized as per the patient's requirements.

Bitolterol may be contraindicated under the following conditions:

• Hypersensitivity to the ingredients of the medication.

As Bitolterol is absorbed only to a very limited extent, no action other than medical observation should be necessary alone or with symptomatic treatment if any symptoms appear.

Pharmacodynamics

Bitolterol, which is an adrenergic bronchodilator, is said to be a prodrug that widens constricted airways in the lungs resulting in relaxing the smooth muscles which surround the bronchial passages. Bitolterol is said to probably not affect the inflammation in the lung, such as in the case of bronchitis. Bitolterol is said to be unique in that it is a prodrug because it has to be first metabolized by the body before it becomes active.

1. https://pubchem.ncbi.nlm.nih.gov/compound/Bitolterol#section=Drug-and-Medication-Information
2. https://www.rxwiki.com/bitolterol
3. https://go.drugbank.com/drugs/DB00901